Therapy-Related Myeloid Neoplasm Has a Higher Subclonal Mutation Burden Than De Novo AML

被引：0
|
作者：
Zheng, Gang [1 ]
Pallavajjalla, Aparna [1 ]
Haley, Lisa [1 ]
Lin, Ming-Tseh [1 ]
Eshleman, James R. [1 ]
Gondek, Lukasz [1 ]
Borowitz, Michael [1 ]
Duffield, Amy [1 ]
Burns, Kathleen H. [1 ]
Gocke, Christopher D. [1 ]
机构：
[1] Johns Hopkins Univ Hosp, Baltimore, MD 21287 USA
来源：
LABORATORY INVESTIGATION | 2017年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1555
引用
收藏
页码：388A / 388A
页数：1
相关论文
共 50 条
  • [41] Therapy-related myeloid sarcoma with an NPM1 mutation
    Bhatta, Sumita
    Kut, Victoria
    Petronic-Rosic, Vesna
    Hyjek, Elizabeth
    Larson, Richard A.
    LEUKEMIA & LYMPHOMA, 2010, 51 (11) : 2130 - 2131
  • [42] Mutation Profiling of Therapy-Related Myeloid Neoplasms Using Next-Generation Sequencing Demonstrates Distinct Profiles from De Novo Disease
    Shih, Alan H.
    Rapaport, Franck
    Chung, Stephen S.
    Dolezal, Emily K.
    Hobson, Sean
    Amato, Mary K.
    Park, Christopher Y.
    Sekeres, Mikkael A.
    van den Brink, Marcel R. M.
    Nimer, Stephen
    Levine, Ross L.
    Maciejewski, Jaroslaw P.
    Klimek, Virginia M.
    BLOOD, 2014, 124 (21)
  • [43] De Novo and Therapy-Related Myelodysplastic Syndromes: Analogies and Differences
    Leone, Giuseppe
    Fabiani, Emiliano
    Voso, Maria Teresa
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2022, 14
  • [44] A Comparison of Therapy-Related and De Novo Chronic Myelomonocytic Leukemia
    Ordobazari, A.
    Olteanu, H.
    Kroft, S. H.
    Harrington, A. M.
    LABORATORY INVESTIGATION, 2014, 94 : 369A - 369A
  • [45] Karyotype and therapy-related acute myeloid leukemia (t-AML) both are independent prognostic parameters: An analysis of 93 patients with t-AML and 1091 patients with de novo AML.
    Schoch, C
    Kern, W
    Schnittger, S
    Dugas, M
    Sauerland, MC
    Heinecke, A
    Buechner, T
    Haferlach, T
    Hiddemann, W
    BLOOD, 2002, 100 (11) : 324A - 325A
  • [46] Therapy-related MDS after curative intensive therapy for de novo acute myeloid leukemia - An emerging clinical entity?
    Helas, S.
    Roellig, C.
    Duehrsen, U.
    Herbst, R.
    Schaich, M.
    Thiede, C.
    Mohr, B.
    Kramer, M.
    Trautmann-Grill, K.
    Von Bonin, M.
    Bornhaeuser, M.
    Ehninger, G.
    Platzbecker, U.
    LEUKEMIA RESEARCH, 2013, 37 : S139 - S139
  • [47] Therapy-related acute myeloid leukemia with inv(16) after successful therapy for de novo acute myeloid leukemia with t(8;21)
    Shao, Haigang
    Yang, Qian
    Wu, Chunxiao
    Cen, Jiannong
    Chen, Suning
    Pan, Jinlan
    ANNALS OF HEMATOLOGY, 2017, 96 (12) : 2127 - 2129
  • [48] Case Report and Literature Review: Therapy-Related Myelodysplastic Syndrome/Acute Myeloid Leukemia with del(7)(q22) in a Patient with De Novo AML
    Kim, Yang Gyun
    Cho, Sun Young
    Park, Tae Sung
    Oh, Seung Hwan
    Yoon, Hwi-Joong
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2011, 41 (01): : 79 - 83
  • [49] Therapy-related acute myeloid leukemia with inv(16) after successful therapy for de novo acute myeloid leukemia with t(8;21)
    Haigang Shao
    Qian Yang
    Chunxiao Wu
    Jiannong Cen
    Suning Chen
    Jinlan Pan
    Annals of Hematology, 2017, 96 : 2127 - 2129
  • [50] Therapy-related acute myeloid leukaemia with mutated NPM1:: treatment induced or de novo in origin?
    Falini, B.
    LEUKEMIA, 2008, 22 (05) : 891 - 892
12345